2023 Q4 Form 10-Q Financial Statement

#000149315223040221 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $2.896M $3.003M $3.287M
YoY Change -9.69% -8.63% -20.51%
Cost Of Revenue $2.653M $2.972M $3.257M
YoY Change -14.49% -8.75% -19.96%
Gross Profit $243.1K $31.55K $30.41K
YoY Change 132.53% 3.74% -54.17%
Gross Profit Margin 8.39% 1.05% 0.93%
Selling, General & Admin $22.36K $15.35K $12.98K
YoY Change 53.15% 18.26% -83.2%
% of Gross Profit 9.2% 48.65% 42.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $50.00 $55.00 $211.00
YoY Change 0.0% -73.93% -71.49%
% of Gross Profit 0.02% 0.17% 0.69%
Operating Expenses $30.23K $100.1K $20.95K
YoY Change 25.07% 377.82% -75.78%
Operating Profit $212.8K -$68.57K $9.457K
YoY Change 164.85% -825.11% -146.93%
Interest Expense $59.35K -$23.16K $1.443K
YoY Change -54.66% -1704.99% -102.86%
% of Operating Profit 27.89% 15.26%
Other Income/Expense, Net -$23.16K -$68.86K
YoY Change -66.37%
Pretax Income $272.2K -$91.73K -$59.40K
YoY Change -107.56% 54.43% -82.05%
Income Tax $2.400K
% Of Pretax Income 0.88%
Net Earnings $269.8K -$91.73K -$59.40K
YoY Change -107.49% 54.43% -82.05%
Net Earnings / Revenue 9.32% -3.05% -1.81%
Basic Earnings Per Share -$0.02 -$0.01
Diluted Earnings Per Share $0.05 -$0.02 -$14.40K
COMMON SHARES
Basic Shares Outstanding 5.022M shares 5.022M shares 4.126M shares
Diluted Shares Outstanding 5.022M shares 4.126M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.79K $18.08K $33.15K
YoY Change -17.38% -45.46% -11.53%
Cash & Equivalents $13.79K $18.08K $33.15K
Short-Term Investments
Other Short-Term Assets $9.330K $15.37K $5.240K
YoY Change 80.81% 193.32% 16.7%
Inventory $2.088M $1.795M $1.439M
Prepaid Expenses $9.327K $15.37K $5.236K
Receivables
Other Receivables
Total Short-Term Assets $2.111M $1.829M $1.477M
YoY Change 19.01% 23.78% 25.69%
LONG-TERM ASSETS
Property, Plant & Equipment $37.32K $258.00 $479.00
YoY Change 8701.89% -46.14% -98.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $37.32K $1.683K $15.54K
YoY Change 223.45% -89.17% -49.44%
TOTAL ASSETS
Total Short-Term Assets $2.111M $1.829M $1.477M
Total Long-Term Assets $37.32K $1.683K $15.54K
Total Assets $2.148M $1.831M $1.493M
YoY Change 20.33% 22.61% 23.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $544.8K $531.5K $482.0K
YoY Change 19.76% 10.26% 3296.9%
Deferred Revenue
YoY Change
Short-Term Debt $25.68K $12.20K $360.8K
YoY Change 328.0% -96.62% 408.15%
Long-Term Debt Due $8.370K $7.530K $3.170K
YoY Change 65.74% 137.54%
Total Short-Term Liabilities $615.2K $587.5K $882.3K
YoY Change 22.48% -33.41% 25.6%
LONG-TERM LIABILITIES
Long-Term Debt $141.6K $142.5K $146.8K
YoY Change -2.29% -2.97% -18.54%
Other Long-Term Liabilities $20.89K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $162.5K $142.5K $146.8K
YoY Change 12.12% -2.97% -24.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $615.2K $587.5K $882.3K
Total Long-Term Liabilities $162.5K $142.5K $146.8K
Total Liabilities $777.7K $730.0K $1.029M
YoY Change 20.16% -29.07% 14.63%
SHAREHOLDERS EQUITY
Retained Earnings -$65.91M -$66.18M -$62.32M
YoY Change -0.01% 6.2%
Common Stock $502.00 $502.00 $412.00
YoY Change 4.37% 21.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.370M $1.101M $463.8K
YoY Change
Total Liabilities & Shareholders Equity $2.148M $1.831M $1.493M
YoY Change 20.33% 22.61% 23.78%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $269.8K -$91.73K -$59.40K
YoY Change -107.49% 54.43% -82.05%
Depreciation, Depletion And Amortization $50.00 $55.00 $211.00
YoY Change 0.0% -73.93% -71.49%
Cash From Operating Activities -$17.76K -$4.010K -$82.97K
YoY Change -74.05% -95.17% 20.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.47K 12.21K 87.39K
YoY Change -74.1% -86.03% 22.39%
NET CHANGE
Cash From Operating Activities -17.76K -4.010K -82.97K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 13.47K 12.21K 87.39K
Net Change In Cash -4.290K 8.200K 4.420K
YoY Change -73.92% 85.52% 61.9%
FREE CASH FLOW
Cash From Operating Activities -$17.76K -$4.010K -$82.97K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001559157
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q3 SSOK Lawsuit Judgement
LawsuitJudgement
usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q3 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
usd
CY2022Q3 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54830
dei Entity Registrant Name
EntityRegistrantName
SUNSTOCK, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1856372
dei Entity Address Address Line1
EntityAddressAddressLine1
111 Vista Creek Circle
dei Entity Address City Or Town
EntityAddressCityOrTown
Sacramento
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95835
dei City Area Code
CityAreaCode
916
dei Local Phone Number
LocalPhoneNumber
860-9622
dei Security12g Title
Security12gTitle
Common Stock.
dei Trading Symbol
TradingSymbol
SSOK.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5021857 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18081 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16691 usd
CY2023Q3 SSOK Inventory Coins Current
InventoryCoinsCurrent
1041875 usd
CY2022Q4 SSOK Inventory Coins Current
InventoryCoinsCurrent
950637 usd
CY2023Q3 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
753490 usd
CY2022Q4 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
801022 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15373 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5155 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1828819 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1773505 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
258 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1425 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11114 usd
CY2023Q3 us-gaap Assets
Assets
1830502 usd
CY2022Q4 us-gaap Assets
Assets
1785043 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
566371 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1425 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11114 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
7526 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
5047 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
587526 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
502298 usd
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
142474 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
144953 usd
CY2023Q3 us-gaap Liabilities
Liabilities
730000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
647251 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5021857 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5021857 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4815857 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4815857 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
502 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
481 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67279869 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67053289 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66179869 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65915978 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1100502 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1830502 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1785043 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3003336 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3287179 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9501467 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9807089 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
2971787 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
3256768 usd
us-gaap Cost Of Revenue
CostOfRevenue
9389237 usd
us-gaap Cost Of Revenue
CostOfRevenue
9633215 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
31549 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
30411 usd
us-gaap Gross Profit
GrossProfit
112230 usd
us-gaap Gross Profit
GrossProfit
173874 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
15353 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
12793 usd
us-gaap Professional Fees
ProfessionalFees
97634 usd
us-gaap Professional Fees
ProfessionalFees
98806 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
182 usd
us-gaap Share Based Compensation
ShareBasedCompensation
738 usd
CY2023Q3 SSOK Lawsuit Judgement
LawsuitJudgement
77863 usd
SSOK Lawsuit Judgement
LawsuitJudgement
77863 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
6907 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
7979 usd
us-gaap Other Expenses
OtherExpenses
23388 usd
us-gaap Other Expenses
OtherExpenses
26319 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
100123 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
20954 usd
us-gaap Operating Expenses
OperatingExpenses
198885 usd
us-gaap Operating Expenses
OperatingExpenses
125863 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-68574 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9457 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-86655 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
48011 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-21556 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-62779 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-47532 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-113775 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
123600 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23160 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-68859 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-177236 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-99075 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91734 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59402 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-263891 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51064 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-91734 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59402 usd
us-gaap Net Income Loss
NetIncomeLoss
-263891 usd
us-gaap Net Income Loss
NetIncomeLoss
-51064 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5021857 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5021857 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4126387 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4126387 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4892069 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4892069 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4126387 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4126387 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
514911 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
102893 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
617804 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-94555 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
523249 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59402 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
463847 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
226601 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-160511 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1192236 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1192236 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-91734 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-91734 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1100502 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1100502 usd
us-gaap Net Income Loss
NetIncomeLoss
-263891 usd
us-gaap Net Income Loss
NetIncomeLoss
-51064 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-47532 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-113775 usd
us-gaap Depreciation
Depreciation
166 usd
us-gaap Depreciation
Depreciation
806 usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
123600 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
91238 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
160162 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10218 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-419 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
91754 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-78233 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102295 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-204709 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
103685 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
207687 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103685 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
207687 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1390 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2978 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16691 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30168 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18081 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33146 usd
SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
30250 usd
us-gaap Stock Issued1
StockIssued1
103000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zRJ3EpwDrAnc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zVoDvlNGux9f">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed and consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by the Company’s management include realizability and valuation of inventories and value of stock-based transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zw6bGLpEtCF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zqnyFDdyaqCh">CONCENTRATION OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of September 30, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-21556 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-62779 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-47532 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-113775 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66179869 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58202 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58036 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
258 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
211 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
166 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
805 usd
CY2023Q3 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
338171 usd
CY2022Q4 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
260308 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133691 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
131500 usd
CY2023Q3 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
14520 usd
CY2022Q4 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
8089 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4631 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
18765 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14436 usd
CY2023Q3 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
12431 usd
CY2022Q4 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
16176 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12467 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8671 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
566371 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2023Q3 SSOK Lawsuit Judgement
LawsuitJudgement
77863 usd
SSOK Lawsuit Judgement
LawsuitJudgement
77863 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
14155 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8940 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8940 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8940 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8940 usd
CY2023Q3 SSOK Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
200405 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
250320 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
100320 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
150000 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
7526 usd
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
142474 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P26Y8M12D
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0 shares

Files In Submission

Name View Source Status
ssok-20230930_pre.xml Edgar Link unprocessable
0001493152-23-040221-index-headers.html Edgar Link pending
0001493152-23-040221-index.html Edgar Link pending
0001493152-23-040221.txt Edgar Link pending
0001493152-23-040221-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssok-20230930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ssok-20230930_cal.xml Edgar Link unprocessable
ssok-20230930_def.xml Edgar Link unprocessable
ssok-20230930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed